Addex Therapeutics Stock In The News

ADXN Stock  USD 8.15  0.02  0.25%   
The analysis of Addex Therapeutics' news coverage and content from conventional and social sources shows investors' indifference towards Addex Therapeutics. The specific impact of Addex Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Addex Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher. Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Addex Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Addex Therapeutics Backtesting and Addex Therapeutics Hype Analysis.
To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.

Addex Therapeutics Today Top News and Investor Outlook

seekingalpha News
Stalicla secures CHF 2M investment led by Addex for neuropsychiatric drug development
https://seekingalpha.com/news/4463543-stalicla-secures-chf-2m-investment-led-by-addex-for-neuropsychiatric-drug-development?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
 Bullish
Investing News at Macroaxis
Earnings call transcript: Addex Therapeutics highlights Q1 2025 progress
https://www.investing.com/news/transcripts/earnings-call-transcript-addex-therapeutics-highlights-q1-2025-progress-93CH-4103010
 Bullish
seekingalpha News
Addex Therapeutics GAAP EPS of -CHF 0.01, income of CHF 0.07M
https://seekingalpha.com/news/4459750-addex-therapeutics-gaap-eps-of-chf-001-income-of-chf-007m?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
 Neutral
nasdaq News
Addex Therapeutics Q1 Loss Narrows Amid Sharply Lower Income
https://www.nasdaq.com/articles/addex-therapeutics-q1-loss-narrows-amid-sharply-lower-income
 Neutral
Yahoo News
Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Highlights: Strategic Partnerships and ...
https://finance.yahoo.com/news/addex-therapeutics-ltd-adxn-q3-070152951.html
 Neutral
Yahoo News
Addex Therapeutics Ltd (ADXN) Q2 2024 Earnings Call Transcript Highlights: Key Financials and ...
https://finance.yahoo.com/news/addex-therapeutics-ltd-adxn-q2-070037120.html
 Bullish
Yahoo News
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.02%
https://finance.yahoo.com/news/u-stocks-higher-close-trade-213506207.html
 Neutral
Yahoo News
Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder
https://finance.yahoo.com/news/johnson-johnson-partner-addex-therapeutics-124804531.html
 Neutral
Yahoo News
Johnson & Johnson-Partnered Addex Therapeutics' Epilepsy Candidate Fails Mid-Stage Study, Stock Tanks
https://finance.yahoo.com/news/johnson-johnson-partnered-addex-therapeutics-165351727.html
 Neutral
Yahoo News
15 Top Performing European Stocks So Far in 2024
https://finance.yahoo.com/news/15-top-performing-european-stocks-085734002.html
 Bullish

Addex Therapeutics Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Addex and other traded companies coverage with news coverage. We help investors stay connected with Addex headlines for the 8th of August to make an informed investment decision based on correlating the impacts of news items on Addex Stock performance. Please note that trading solely based on the Addex Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Addex Therapeutics' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Addex Therapeutics investors visualize upcoming and past events in order to time the market based on Addex Therapeutics noise-free hype analysis.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Addex Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Addex Therapeutics' short interest history, or implied volatility extrapolated from Addex Therapeutics options trading.
When determining whether Addex Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Addex Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Addex Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Addex Therapeutics Stock:
Check out Addex Therapeutics Backtesting and Addex Therapeutics Hype Analysis.
To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(7.43)
Revenue Per Share
0.36
Quarterly Revenue Growth
(0.70)
Return On Assets
(0.25)
Return On Equity
(1.63)
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.